HENGST SE v. Champion Laboratories, Inc.

District Court, N.D. Illinois·Decided December 10, 2024·No. 1:23-cv-00794·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

HENGST SE, ) ) Plaintiff, ) ) No. 23 C 794 v. ) ) Judge Sara L. Ellis CHAMPION LABORATORIES, LLC, ) ) Defendant. )

OPINION AND ORDER Plaintiff Hengst SE (“Hengst”) filed this lawsuit against Defendant Champion Laboratories, LLC (“Champion”), alleging that Champion infringed on Hengst’s patent for a removable and replaceable oil filter, U.S. Patent No. 9,023,203 (the “’203 Patent”). After claim construction proceedings here, the Patent Trial and Appeal Board (“PTAB”) has instituted inter partes review (“IPR”) on Hengst’s patent. Now, Champion brings a motion to stay the proceedings in this Court until the PTAB has completed the IPR and issued its decision. Because a stay pending the PTAB decision would not impose undue prejudice or a tactical disadvantage on Hengst; would simplify and streamline the case; and would likely reduce the burden of litigation on the parties and the Court; the Court grants Champion’s motion to stay. BACKGROUND The ’203 Patent, entitled “Liquid filter,” describes an oil filter with a removable and replaceable filter insert. Hengst filed the instant lawsuit to enforce the ’203 Patent against Champion on February 8, 2023. Hengst alleges that Champion’s Luper-Finer brand oil filter inserts infringe on the ’203 Patent. Specifically, Hengst has asserted the following claims under the ’203 Patent: 15–17, 19, 23–25, 28, and 30. In their time before this Court, the parties have completed fact discovery and claim construction. This Court issued a claim construction ruling on September 17, 2024. The parties have not yet started expert discovery or dispositive motion briefing. The Court has also not yet set a date for trial. On June 5, 2023, Champion submitted, pursuant to Local Patent Rule 2.3, its initial non-

infringement and invalidity contentions (“initial contentions”). On January 16, 2024, Champion submitted its final unenforceability and invalidity contentions (“final contentions”). Pursuant to Local Patent Rule 3.1(d), Champion did not include several invalidity contentions in its final contentions that Champion had included in its initial contentions. On February 22, 2024, Champion filed a petition for IPR. On September 18, 2024, the PTAB granted IPR of claims 1, 3, 5, 8–11, 15–17, 19, 23–25, and 28–30 of the ‘203 Patent. Among other arguments, the PTAB granted IPR on some grounds of unpatentability that Champion raised in its initial contentions before this Court, and not in its final contentions. LEGAL STANDARD District courts have inherent power to control their own dockets, including the power to

stay proceedings before them. Clinton v. Jones, 520 U.S. 681, 706 (1997) (“The District Court has broad discretion to stay proceedings as an incident to its power to control its own docket.”). How best to manage the Court’s docket “calls for the exercise of judgment, which must weigh competing interests and maintain an even balance.” Landis v. N. Am. Co., 299 U.S. 248, 254–55, (1936). Specifically, the Court has the discretion “to stay a case pending reexamination of a patent in suit.” Beijing Choice Elec. Tech. Co. v. Contec Med. Sys. USA Inc., No. 18-cv-00825, 2024 WL 4784283, at *1 (N.D. Ill. Sept. 27, 2024) (citing Procter & Gamble Co. v. Kraft Foods Glob., Inc., 549 F.3d 842, 848–49 (Fed. Cir. 2008)). District courts consider three factors in determining whether to grant a stay pending IPR: (1) whether the stay will unduly prejudice or tactically disadvantage the nonmoving party; (2) whether the stay will simplify the issues in question and streamline the trial; and (3) whether the stay will reduce the burden of litigation on the parties and on the court. Ignite USA, LLC v. Pac. Mkt. Int’l, LLC, No. 14 C 856, 2014 WL 2505166, at *2 (N.D. Ill. May 29, 2014) (citing Black & Decker Inc. v. Positec USA, Inc., No.

13-3075, 2013 WL 5718460, at *3 (N.D. Ill. Oct. 1, 2013)). ANALYSIS I. Undue Prejudice and Tactical Disadvantage First, the Court considers whether Hengst would suffer any undue prejudice or tactical disadvantages from Champion’s proposed stay. Hengst argues a stay would disadvantage and prejudice it because Champion has engaged in gamesmanship by asserting grounds for unpatentability in its arguments before the PTAB that it raised in its initial contentions but did not pursue in its final contentions before this Court. Hengst contends that Champion chose the PTAB as its “preferred forum to relitigate” these contentions that it had seemingly abandoned. Doc. 46 at 7. Hengst further argues that Champion’s conduct reflects an attempt to delay

proceedings and gain a tactical advantage because this Court’s Local Patent Rules limit defendants to four prior art grounds per claim in their final invalidity contentions. See N.D. Ill. Local Patent Rule 3.1(d). This Court finds Hengst’s arguments unpersuasive and instead concludes that Champion’s conduct does not result in undue prejudice or tactical disadvantage to Hengst. First, to the extent that Hengst argues it would be prejudiced or disadvantaged by the delay from the IPR, such an argument fails because “[d]elay, in and of itself, does not constitute undue prejudice.” Oil-Dri Corp. v. Nestle Purina Petcare Co., No. 15-cv-1067, 2015 WL 13650951, at *2 (N.D. Ill. May 5, 2015) (citing Black & Decker Inc., 2013 WL 5718460, at *2). As for Hengst’s other argument, this Court’s Local Patent Rules contemplate that defendants will streamline, condense, and change their grounds for invalidity as a case progresses towards trial. See Shure, Inc. v. ClearOne, Inc., No. 17 C 3078, 2018 WL 1371170, at *9 n.16 (N.D. Ill. Mar. 16, 2018) (“The Local Patent Rules do allow (and even expect) parties

to amend and update their contentions.”). By comparison, under the authority that governs IPR, petitioners are incentivized to bring all colorable grounds in their petitions for IPR or else face estoppel of all claims or grounds that they could have asserted. See Boston Sci. Corp. v. Cook Grp. Inc., 653 F. Supp. 3d 541, 588 (S.D. Ind. 2023) (describing that under 35 U.S.C. § 315(e)(2), “[t]he petitioner in an inter parties review of a claim in a patent . . . that results in a final written decision . . . may not assert either in a civil action arising in whole or in part under section 1338 of title 28 . . . that the claim is invalid on any ground that the petitioner raised or reasonably could have raised during that inter partes review” (emphasis in original)). Because the system for IPR requires petitioners to bring all of their arguments or face waiver and in contrast, this Court’s rules require parties to narrow their claims to the most persuasive, it does

not appear to be impermissible gamesmanship for a petitioner to raise arguments in their IPR petition that they did not pursue in their final invalidity contentions. See Hill-Rom Servs., Inc. v. Stryker Corp., No. 1:11–cv–1120–JMS–DKL, 2012 WL 5878087, at *3 (S.D. Ind. Nov. 20, 2012) (rejecting an argument that a party would be at a tactical disadvantage because the party that moved for IPR could assert inconsistent positions before the PTAB). Hengst also has not identified any authority to support that raising different grounds with the PTAB than with the district court amounts to unfair prejudice or a tactical disadvantage. The lack of undue prejudice or tactical disadvantage to Hengst weighs in favor of granting a stay. II.

Free access — add to your briefcase to read the full text and ask questions with AI

HENGST SE v. Champion Laboratories, Inc., (N.D. Ill. 2024).

HENGST SE v. Champion Laboratories, Inc. (HENGST SE v. Champion Laboratories, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Landis v. North American Co.
299 U.S. 248 (Supreme Court, 1936)
Clinton v. Jones
520 U.S. 681 (Supreme Court, 1997)
Procter & Gamble Co. v. Kraft Foods Global, Inc.
549 F.3d 842 (Federal Circuit, 2008)
United States v. Diggs
385 F. Supp. 3d 648 (E.D. Illinois, 2019)